Paeoniflorin alleviates depression by inhibiting the activation of NLRP3 inflammasome via promoting mitochondrial autophagy

Abstract

Depression ranks among the most common neuropsychiatric disorders globally. Current studies examining the roles of inflammation and mitochondrial autophagy in the antidepressant efficacy of paeoniflorin (PF) are sparse. This study aimed to elucidate PF’s antidepressant mechanism by promoting autophagy and inhibiting NLRP3 inflammasome activation using chronic unpredictable mild stimulation (CUMS)-induced C57BL/6 mouse models in vivo and corticosterone (CORT)-induced HT22 cell models in vitro. Results demonstrated that PF enhanced the viability of HT22 cells following CORT exposure, restored mitochondrial membrane potential (MMP), reduced reactive oxygen species accumulation, increased LC3 fluorescence intensity, and suppressed inflammatory cytokine secretion and inflammation activation. Additionally, PF ameliorated depressive behaviors induced by CUMS and improved damage in hippocampal neurons. It also reduced the expression of NLRP3, ASC, Caspase-1, IL-1β, and the assembly of the NLRP3 inflammasome. Moreover, PF upregulated the expression of autophagy-related proteins in the hippocampus, facilitating the clearance of damaged mitochondria and enhancing autophagy. The role of autophagy in PF’s antidepressant effects was further confirmed through the use of the autophagy inhibitor 3-methyladenine (3-MA), which reduced the efficacy of PF. In conclusion, PF effectively improved depressive behaviors in CUMS-induced mice and reduced NLRP3-mediated inflammation both in vivo and in vitro, likely via the induction of autophagy.

Keywords

Paeoniflorin / Depression / Autophagy / NLRP3 inflammasome

References

[1] Liu H, He YL, Wang JY, et al. Epidemiology of depression at Traditional Chinese Medicine Hospital in Shanghai, China[J]. Compr Psychiatry, 2016, 65: 1-8.

[2] Rice F, Riglin L, Lomax T, et al. Adolescent and adult differences in major depression symptom profiles[J]. J Affect Disord, 2019, 243: 175-181.

[3] Mukherjee N, Chaturvedi SK. Depressive symptoms and disorders in type 2 diabetes mellitus[J]. Curr Opin Psychiatr, 2019, 32(5): 416-421.

[4] Maamri A, Ghabi H, Zalila H. Parkinson’s disease and depression[J]. Eur Psychiatr, 2021, 64: S240-S240.

[5] Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer[J]. BMJ, 2018, 361: k1415.

[6] Dwyer J B, Aftab A, Radhakrishnan R, et al. Hormonal treatments for major depressive disorder: state of the art[J]. Am J Psychiatr, 2020, 177(8): 686-705.

[7] Chen L, Zhao X, Wei S, et al. Mechanism of paeoniflorin on ANIT-induced cholestatic liver injury using integrated metabolomics and network pharmacology[J]. Front Pharmacol, 2021, 12: 737630.

[8] Li Y, Yin S, Chen X, et al. The inhibitory effect of paeoniflorin on reactive oxygen species alleviates the activation of NF-kappaB and MAPK signalling pathways in macrophages[J]. Microbiology, 2022, 168(8): 001210.

[9] Niu K, Liu Y, Zhou Z, et al. Antitumor effects of paeoniflorin on Hippo signaling pathway in gastric cancer cells[J]. J Oncol, 2021, 2021: 4724938.

[10] Han X, Hu S, Yang Q, et al. Paeoniflorin ameliorates airway inflammation and immune response in ovalbumin induced asthmatic mice: from oxidative stress to autophagy[J]. Phytomedicine, 2022, 96: 153835.

[11] Guo K, Zhang Y, Li L, et al. Neuroprotective effect of paeoniflorin in the mouse model of Parkinson’s disease through alpha-synuclein/protein kinase C delta subtype signaling pathway[J]. Neuroreport, 2021, 32(17): 1379-1387.

[12] Zhang Y, Qiao L, Xu W, et al. Paeoniflorin attenuates cerebral ischemia-induced injury by regulating Ca(2 + )/CaMKII/CREB signaling pathway[J]. Molecules, 2017, 22(3): 359.

[13] Qiu F, Zhong X, Mao Q, et al. The antidepressant-like effects of paeoniflorin in mouse models[J]. Exp Ther Med, 2013, 5(4): 1113-1116.

[14] Li YC, Zheng XX, Xia SZ, et al. Paeoniflorin ameliorates depressive-like behavior in prenatally stressed offspring by restoring the HPA axis-and glucocorticoid receptor- associated dysfunction[J]. J Affect Disord, 2020, 274: 471-481.

[15] Tang M, Chen M, Li Q. Paeoniflorin ameliorates chronic stress-induced depression-like behavior in mice model by affecting ERK1/2 pathway[J]. Bioengineered, 2021, 12(2): 11329-11341.

[16] Cheng J, Chen M, Wan HQ, et al. Paeoniflorin exerts antidepressant-like effects through enhancing neuronal FGF-2 by microglial inactivation[J]. J Ethnopharmacol, 2021, 274: 114046.

[17] Deretic V, Levine B. Autophagy balances inflammation in innate immunity[J]. Autophagy, 2018, 14(2): 243-251.

[18] Ktistakis NT, Tooze SA. Digesting the expanding mechanisms of autophagy[J]. Trends Cell Biol, 2016, 26(8): 624-635.

[19] Li C, Zhu Y, Wu Y, et al. Oridonin alleviates LPS-induced depression by inhibiting NLRP3 inflammasome via activation of autophagy[J]. Front Med, 2021, 8: 813047.

[20] Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics[J]. Nat Rev Immunol, 2019, 19(8): 477-489.

[21] Ge C, Wang S, Wu X, et al. Quercetin mitigates depression-like behavior via the suppression of neuroinflammation and oxidative damage in corticosterone-induced mice[J]. J Chem Neuroanat, 2023, 2023: 102313.

[22] Zhou Z, Wang Y, Sun S, et al. Paeonia lactiflora Pall. Polysaccharide alleviates depression in CUMS mice by inhibiting the NLRP3/ASC/Caspase-1 signaling pathway and affecting the composition of their intestinal flora[J]. J Ethnopharmacol, 2023, 316: 116716.

[23] Ye JS, Chen L, Lu YY, et al. Honokiol-mediated mitophagy ameliorates postoperative cognitive impairment induced by surgery/sevoflurane via inhibiting the activation of NLRP3 inflammasome in the hippocampus[J]. Oxid Med Cell Longev, 2019, 2019: 8639618.

[24] Chen K, Feng L, Hu W, et al. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy[J]. FASEB J, 2019, 33(3): 4571-4585.

[25] Lyu D, Wang F, Zhang M, et al. Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway[J]. Psychopharmacology, 2022, 239(10): 3201-3212.

[26] Lu R, Zhang L, Yang X. Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease[J]. Front Aging Neurosci, 2022, 14: 1018848.

[27] Shu X, Sun Y, Sun X, et al. The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression[J]. Cell Death Dis, 2019, 10(8): 577.

[28] Sun X, Zhang T, Zhao Y, et al. Panaxynol attenuates CUMS-induced anxiety and depressive-like behaviors via regulating neurotransmitters, synapses and the HPA axis in mice[J]. Food Funct, 2020, 11(2): 1235-1244.

[29] Willner P, Towell A, Sampson D, et al. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant[J]. Psychopharmacology (Berl), 1987, 93(3): 358-64.

[30] Carola V, D'Olimpio F, Brunamonti E, et al. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice[J]. Behav Brain Res, 2002, 134(1-2): 49-57.

[31] Perez-Caballero L, Torres-Sanchez S, Bravo L, et al. Fluoxetine: a case history of its discovery and preclinical development[J]. Expert Opin Drug Discov, 2014, 9(5): 567-578.

[32] Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders[J]. Biol Psychiatry, 2006, 59(12): 1116-1127.

[33] Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder[J]. Clin Psychiatry, 2008, 69 Suppl E1: 4-7.

[34] Brakel K, Hook MA. SCI and depression: does inflammation commandeer the brain?[J]. Exp Neurol, 2019, 320: 112977.

[35] Yang Y, Wang H, Kouadir M, et al. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors[J]. Cell Death Dis, 2019, 10(2): 128.

[36] Troubat R, Barone P, Leman S, et al. Neuroinflammation and depression: a review[J]. Eur J Neurosci, 2021, 53(1): 151-171.

[37] Nguyen C, Boutron I, Baron G, et al. Intradiscal glucocorticoid injection for patients with chronic low back pain associated with active discopathy: a randomized trial[J]. Ann Intern Med, 2017, 166(8): 547-556.

[38] Zhao X, Cao F, Liu Q, et al. Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mouse models of depression[J]. Behav Brain Res, 2019, 364: 494-502.

[39] Liu H, You L, Wu J, et al. Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS[J]. J Leukoc Biol, 2020, 108(1): 253-266.

Funding

Jilin Science &Technology Development Plan(20210204001YY)

Jilin Science &Technology Development Plan(20200404090YY)

Jilin Province aid Project for Xinjiang Uygur Autonomous Region(0207-202020043)